ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1401	National Cancer Institute	Html	en	Depression (PDQ®)–Patient Version	Expert-reviewed information summary about the diagnosis, assessment, and treatment of depression in adults and children who have cancer.	cancer treatment 0.651741 talk therapy 0.584553 cancer reacts 0.573578 PDQ cancer information 0.709592 specific symptoms 0.575944 children 0.567594 clinical trials 0.590596 major depression 0.717529 cancer information summary 0.661683 social support 0.596519 family members 0.586314 clinical trial 0.577701 breast cancer prevention 0.582269 risk factors 0.576392 cancer patients 0.640384 suicide 0.586542 cancer diagnosis 0.641499 daily life 0.565808 usual activities 0.591649 nerve cells 0.617277 symptoms 0.713409 NCI PDQ cancer 0.615822 anxiety 0.567307 effects 0.576095	treatment 0.684675 medicines 0.607072 Cancer Information Service 0.595317 personal history 0.608756 pancreatic cancer 0.571142 treatment clinical trials 0.568602 National Cancer Institute 0.658955 health care 0.575207 Palliative Care Editorial 0.599921 tricyclic antidepressants 0.564862 cancer pain 0.568074 new treatment 0.572603 Cancer Care page 0.585295 Care Editorial Board 0.601242 antidepressants 0.660082 active cancer treatment 0.606386 PDQ summary 0.608172 doctor 0.608478 cancer-related depression 0.600613 cancer information summaries 0.594088 comprehensive cancer information 0.593479 cancer 0.885163 depression 0.980341 reuptake inhibitors 0.578298	CLICK HERE
1503	National Cancer Institute	Html	en	Ovarian Germ Cell Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of ovarian germ cell tumors.	adjuvant chemotherapy 0.587693 pure dysgerminoma 0.480069 Oncology Group trials 0.399123 endodermal sinus tumor 0.426786 chemotherapy 0.67435 PDQ cancer information 0.453857 incompletely resected tumors 0.456006 cancer information summary 0.450698 high-dose chemotherapy 0.414186 recurrent germ cell 0.415503 durable remission 0.43875 radiographic procedures 0.437608 para-aortic lymph nodes 0.495597 patients 0.944817 intact ovary 0.411146 Surgical resection 0.432079 adjuvant therapy 0.398709 higher stage tumors 0.443399 total abdominal hysterectomy 0.474933 Gynecologic Oncology Group 0.490243 Endodermal sinus tumors 0.452987 radiation therapy 0.487845 immature teratoma 0.464025 modern chemotherapeutic era 0.398622 advanced stage dysgerminoma 0.404048	ovarian germ cell 0.413493 clinical examination 0.424181 primary tumor. 0.431827 residual masses 0.43388 well-staged patients 0.406144 fallopian tube 0.401507 completely resected tumors 0.468623 BEP combination chemotherapy 0.509951 cisplatin-based adjuvant treatment. 0.511465 maximal surgical debulking 0.469791 adjuvant setting 0.44443 endodermal sinus 0.463622 Second-look surgery 0.421726 disease 0.413051 large tumors 0.399492 mixed germ cell 0.430258 combination chemotherapy 0.637036 salvage therapy. 0.435874 cisplatin-containing combination chemotherapy 0.471327 stage IA tumors 0.445257 germ cell tumors 0.871083 stage 0.462819 initial surgical procedure 0.530199 Cisplatin-based combination chemotherapy 0.476734	CLICK HERE
1523	National Cancer Institute	Html	en	Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of ovarian epithelial, fallopian tube, and primary peritoneal cancer.	Peritoneal Cancer Prevention 0.227525 treatment 0.390762 cancer treatment 0.235396 Peritoneal Cancer Treatment 0.215309 cancer cells 0.337677 body 0.222684 PDQ cancer information 0.234419 ovarian epithelial cancer 0.590068 fallopian tube cancers 0.219247 fallopian tube 0.872006 advanced ovarian epithelial 0.202336 fallopian tube cancer 0.492956 National Cancer Institute 0.246576 primary peritoneal cancer 0.750448 clinical trials 0.486834	cancer information summary 0.212408 clinical trial 0.300455 new treatment 0.206874 PDQ Ovarian Epithelial 0.215884 ovarian cancer 0.427345 patients 0.208263 primary peritoneal cancers 0.298007 peritoneal cancer form 0.23692 Recurrent ovarian epithelial 0.234027 Hereditary ovarian cancer 0.23385 cancer clinical trials 0.21629 stage 0.222725 fallopian tubes 0.310827 cancer 0.950591 information 0.260881	CLICK HERE
1578	National Cancer Institute	Html	en	Salivary Gland Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of salivary gland cancer.	treatment 0.350503 cancer cells 0.273747 salivary gland tumors 0.252711 body 0.202362 Recurrent salivary gland 0.246617 PDQ cancer information 0.209396 clinical trial search 0.221183 National Cancer Institute 0.225088 clinical trials 0.502843 clinical trial 0.428553 fast neutron radiation 0.275402 patients 0.211575	salivary glands 0.27815 small salivary gland 0.219313 major salivary gland 0.219682 salivary gland cancer 0.977675 cancer clinical trials 0.23079 lymph node 0.201663 radiation therapy 0.594263 salivary gland cancers 0.255838 information 0.215378 diagnose salivary gland 0.246491 Minor salivary gland 0.204078 neutron radiation therapy 0.270686	CLICK HERE
1594	National Cancer Institute	Html	en	Gallbladder Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of gallbladder cancer.	Primary gallbladder cancer 0.47032 bile ducts 0.484867 tissue 0.379314 body 0.404589 Gallbladder Cancer Treatment 0.453363 PDQ cancer information 0.441195 clinical trial search 0.374973 bile duct 0.37352 Endoscopic stent placement 0.366691 nearby lymph nodes 0.402642 cancer information summary 0.414802 clinical trial 0.522846 breast cancer prevention 0.364901 liver 0.416883 gallbladder surgery 0.402266 gallbladder stores 0.412552 patients 0.384079 blood vessels 0.366084 metastatic gallbladder cancer 0.515618 Unresectable cancer 0.362347 treatment clinical trial 0.366014 NCI PDQ cancer 0.38278 radiation therapy 0.532352 Treatment Editorial Board 0.368907	small intestine 0.483884 treatment 0.503531 gallbladder cancer 0.938706 transhepatic biliary drainage 0.367562 new cancer treatments 0.372521 NCI-supported cancer 0.364603 cancer cells 0.513548 Cancer Information Service 0.372954 common bile duct 0.365877 treatment clinical trials 0.389845 gallbladder cancer cells 0.455848 National Cancer Institute 0.416909 new treatment 0.406145 External radiation therapy 0.364544 stage gallbladder cancer 0.491411 ) layer. 0.384877 clinical trials 0.742882 Cancer Care page 0.364553 Blood. The cancer 0.370595 cancer research process 0.366097 cancer clinical trials 0.40814 tumor 0.374261 cancer information summaries 0.371259 comprehensive cancer information 0.371502	CLICK HERE
1826	National Cancer Institute	Html	es	Tratamiento del retinoblastoma (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del retinoblastoma en niños.	Fam Cancer 0.224979 second primary 0.226983 Moll AC 0.230701 bilateral retinoblastoma 0.377316 bilateral retinoblastoma treated 0.303483 Sin embargo 0.262098 cancers after radiotherapy 0.220083 with retinoblastoma 0.99058 retinoblastoma patients 0.504149 international classification 0.229832 hereditary retinoblastoma 0.609301 Imhof SM 0.218892 tumors among survivors 0.21889 with carboplatin 0.219119 retinoblastoma treated with 0.391051 retinoblastoma —una tasa 0.309551 gen rb1 0.264654 Estados Unidos 0.240611 Natl Cancer Inst 0.380536 patients with 0.285893 second malignant neoplasms 0.222801 ectopic intracranial retinoblastoma 0.30877 survivors treated with 0.222819 retinoblastoma survivors 0.803446 Retinoblastoma Families 0.301592	heritable retinoblastoma survivors 0.400266 long-term survivors 0.281356 orientación genética 0.258139 Abramson DH 0.390414 with retinoblastoma treated 0.311845 rb1 mutations 0.229834 sporadic unilateral retinoblastoma 0.309266 Retinoblastoma Survivor Study 0.395385 Second nonocular tumors 0.222288 Pediatr Blood Cancer 0.370166 retinoblastoma treated 0.437026 novel retinoblastoma 0.302896 Arch Ophthalmol 0.218403 International Retinoblastoma Staging 0.430669 sección retinoblastoma 0.316419 Clin Oncol 0.275713 sistema nervioso central 0.230398 tumor progresa 0.220651 Retinoblastoma Staging System 0.431448 among long-term survivors 0.238413 Shields CL 0.248375 retinoblastoma tumours 0.300442 Marees T 0.232711 retinoblastoma patients reveals 0.307846	CLICK HERE
2000	National Cancer Institute	Html	es	Tratamiento de la histiocitosis de células de Langerhans (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la histiocitosis de células de Langerhans.	cuánto aire 0.415134 siguientes procedimientos 0.528715 células madre 0.858073 adultos jóvenes 0.464664 efectos secundarios meses 0.439126 siguientes aspectos 0.434701 faja ajustadora 0.428231 HCL infantil multisistémica 0.546722 cuántos sistemas 0.518567 genes ras 0.453948 pequeña cantidad 0.423844 células normales.ampliar exploración 0.532323 vía oral 0.42013 rayos x 0.425227 gen braf 0.666188 largo plazo 0.44968 cuántas células 0.518957 niño ayuda 0.426203 efectos tardíos 0.516221 escáner.ampliar exploración 0.429231 tarde.ampliar ecografía 0.427113	vías respiratorias 0.424871 causa problemas 0.424997 lesiones óseas 0.423193 National Cancer Institute 0.417904 IRMN).Ampliar Imágenes 0.421648 siguientes riesgos 0.415861 radiación uvb 0.414555 Instituto Nacional 0.431398 PDQ Tratamiento 0.451873 antecedentes familiares 0.589915 llamada genes ras 0.432872 explorador tep 0.430081 terapia fotodinámica causa 0.453098 sistema nervioso central 0.604707 Physician Data Query 0.464236 mayores probabilidades 0.416225 HCL multisistémica 0.966875 terapia fotodinámica llamada 0.451949 radiación ultravioleta 0.561342 siguientes pruebas 0.489919	CLICK HERE
3423	National Cancer Institute	Html	es	Tintes para el cabello y el riesgo de cáncer	Hoja informativa que analiza las investigaciones sobre la posible conexión entre los tintes para el cabello de uso personal y el cáncer.	Garcia-Closas M 0.306371 Harling M 0.306346 La Vecchia C 0.308404 American Medical Association 0.308091 Personal permanent 0.308814 Costantini AS 0.305724 pequeño aumento 0.306764 lymphoid neoplasms 0.305705 case-control study 0.330749 sustancias químicas llamadas 0.319289 linfoma no-Hodgkin 0.315605 IARC Monographs 0.307567 New England bladder 0.317677 dye products 0.311357 Benvenuti A 0.306313 Occupational Health 0.305772 Sanjose S 0.317218 Estados Unidos 0.315003 resultados contradictorios 0.358008 hematolymphopoietic malignancies 0.305757 PubMed Abstract 0.927635 on carcinogenicity 0.306299 International Agency 0.31736 International Journal 0.345823 análisis conjunto 0.313039	Nieters A 0.306464 Bolt HM 0.305479 Critical Reviews 0.305548 Nienhaus A 0.305624 leucemia aguda 0.319649 non-Hodgkin lymphoma 0.305903 is not 0.31478 Carcinogenic Risks 0.30569 aminas aromáticas 0.321464 Dulon M 0.30623 Epidemiology Biomarkers 0.309054 Thun MJ 0.305441 Etminan M 0.306466 Hamann CR 0.305758 determinados tipos 0.306529 Kogevinas M 0.306372 Aben KK 0.305435 Gago-Dominguez M 0.314868 Sandler DP 0.305457 case-control study from 0.31306 Some Aromatic Amines 0.30908 Schablon A 0.305625 Montes-Martinez A 0.305837 Decarli A 0.305736	CLICK HERE
3567	National Cancer Institute	Html	en	NCI-Designated Cancer Centers	NCI-designated cancer centers are at the forefront of NCI-supported cancer research efforts at universities and cancer research centers across the United States.	Basic Laboratory Cancer 0.40308 cancer prevention 0.219474 United States 0.258952 promising laboratory discoveries 0.246618 successful investigator-initiated grants 0.242213 NCI grant funding 0.273266 cancer center investigators 0.372566 Cancer Centers conduct 0.328404 university medical centers 0.293855 research capabilities 0.206064 individual cancer center 0.29193 fosters cancer programs 0.290926 NCI Cancer Centers 0.39489 cutting-edge cancer treatments 0.306989	cancer research effort 0.342261 Comprehensive Cancer Centers 0.42681 NCI-Designated Cancer Center 0.361383 new treatments 0.264162 cancer patients 0.223724 cancer diagnosis 0.215839 basic laboratory research 0.296921 cancer centers 0.970403 substantial transdisciplinary research 0.27523 cancer clinical trials 0.286407 Laboratory Cancer Centers 0.418647 cancer survivors 0.215279 research studies 0.213208	CLICK HERE
16683	National Cancer Institute	Html	es	714-X (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre el uso del 714-X como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Alternative Medicine Confronts 0.349 Task Force 0.681834 Rock Forest 0.4465 Cancer Research Initiative 0.920081 Radiosensitizing effect 0.323708 but not 0.32369 Goel HC 0.323157 Alternative Therapeutic 0.727518 Bacteria Cause Cancer 0.362108 Unconventional therapies 0.71198 Breast Cancer Research 0.913503 saccharin-LiCl conditioned stimulus 0.34146 Roa AR 0.322774 transplantable mammary 0.323668 Instituto Nacional 0.49296 Pharmacol Biochem Behav 0.342417 Pavlovian conditioning 0.324132 PDQ 714-X 0.384196 posibles efectos 0.32412 Estados Unidos 0.547224 Canadian Breast Cancer 0.923206 for bacteria as 0.342644 vía nasal 0.324957 Purohit A 0.322533 New York University 0.333776	alcanfor mejora 0.352671 Conditioned enhancement 0.324112 linfoma caninos 0.323743 CERBE Distribution 0.468077 Solvason HB 0.367895 Hiramoto RN 0.325133 new approach 0.322794 empresa distribuidora 0.324674 National Cancer Institute 0.431242 Hiramoto NS 0.502986 vitamina b12 0.324597 New York 0.3535 accessed april 0.467486 Neurosci Res 0.325453 numerosos oligoelementos 0.325391 Physician Data Query 0.337084 Hess DJ 0.368799 libre uso 0.325033 linfosarcoma murinos 0.323938 Ghanta VK 0.432317 cartílago bovino 0.325426 killer cell activity 0.342736 response to yc8 0.339588 Soong SJ 0.323559	CLICK HERE